Stock listing
Solasia Pharma Kk
Selected listing: 4597 · TSE · JPY · JP
Solasia Pharma Kk (Tokyo:4597), Health Technology. Latest release Aug 13, 2026: Consolidated Financial Results for the Six Months Ended June 30, 2026 (Under…
- Ticker
- Tokyo:4597
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tokyo
- Currency
- JPY
About Solasia Pharma Kk
Solasia Pharma KK is a publicly traded company on the Japanese market, identified by the ticker 4597. Solasia focuses on developing and commercializing pharmaceuticals, contributing to advancements in healthcare.
Latest news from Solasia Pharma Kk
Consolidated Financial Results for the Six Months Ended June 30, 2026 (Under IFRS)
August 13, 2026
Solasia Announces Launch of Darvias® in Japan
August 22, 2022
Solasia Pharma K K : Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (under IFRS)
August 15, 2022
Solasia Pharma K K : Announces Topline Data from Phase III AGENT Study of SP-05(arfolitixorin)
August 3, 2022
Solasia Pharma K K : Announces Capital and Business Alliance with Nippon Kayaku Co., Ltd.
June 28, 2022
Research Solasia Pharma Kk
Alternate listings
A2DN9S:LSX
DE · EUR
Alternate listing for Solasia Pharma Kk; the primary context on this page is 4597:TSE.
A2DN9S:LS
DE · EUR
Alternate listing for Solasia Pharma Kk; the primary context on this page is 4597:TSE.
9SO:FWB
DE · EUR
Alternate listing for Solasia Pharma Kk; the primary context on this page is 4597:TSE.
9SO:SWB
DE · EUR
Alternate listing for Solasia Pharma Kk; the primary context on this page is 4597:TSE.